Lupin’s shares are in focus following a robust Q1 performance, with net profit surging 52% to Rs 1,221 crore, fueled by strong US and Indian market growth. Sales climbed to Rs 6,164 crore. Nilesh Gupta, MD, highlighted the company’s focus on compliance and innovation for sustainable growth.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets